Target intelligence / Profile preview

GTP binding protein overexpressed in skeletal muscle (GEM)

Target
GEM
Molecular classification
Small GTPase, Member of the RAD/GEM family of GTP-binding proteins, Ras-related protein (Ras superfamily)
01

Overview

GTP binding protein overexpressed in skeletal muscle (GEM) is a member of the RAD/GEM family of small GTP-binding proteins, structurally related to the Ras superfamily[1][4][5][8]. GEM is associated with the inner face of the plasma membrane and is thought to act as a regulatory protein in receptor-mediated signal transduction, especially in the context of cytoskeletal organization and potentially in the modulation of voltage-dependent calcium channel activity[1][2][7]. The GEM gene undergoes alternative splicing but encodes the same protein through at least two transcript variants[4][5][8]. While GEM is not a direct pharmacological target or established therapeutic protein, changes in its expression have been observed in metabolic, neurological, and musculoskeletal disease contexts, indicating a possible role in disease biology rather than as a current intervention point[4][5][7][8].

Other names
GEMKIRKinase-inducible Ras-like proteinRAS-like protein KIRGTP-binding mitogen-induced T-cell proteinGTP-binding protein GEM
02

Mechanism of action

None established, since GEM is not a known direct pharmacological target[4][8].

03

Biological functions

Signal transduction (regulatory protein, participates in receptor-mediated signal transduction)Regulation of cytoskeletal rearrangementRegulation of calcium channel activity (notably L-type voltage-dependent calcium channels)Guanine nucleotide binding (but with undetectable intrinsic GTPase activity)
04

Disease associations

Reported associations with Bardet-Biedl syndrome 19Autism spectrum disorderDysregulation reported in type 2 diabetes (original identification in muscle overexpression in T2D)Possible role in osteoarthritis (modulating Wnt/β-catenin pathway)General implication in signaling pathways altered in cancer, diabetes, and chondrogenesis, though its direct causative or target role remains unclear

Beyond the preview

Go deeper on GTP binding protein overexpressed in skeletal muscle (GEM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GTP binding protein overexpressed in skeletal muscle (GEM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call